The autophagy-lysosome pathway: a potential target in the chemical and gene therapeutic strategies for Parkinson's disease.
Neural Regen Res
; 20(1): 139-158, 2025 Jan 01.
Article
en En
| MEDLINE
| ID: mdl-38767483
ABSTRACT
Parkinson's disease is a common neurodegenerative disease with movement disorders associated with the intracytoplasmic deposition of aggregate proteins such as α-synuclein in neurons. As one of the major intracellular degradation pathways, the autophagy-lysosome pathway plays an important role in eliminating these proteins. Accumulating evidence has shown that upregulation of the autophagy-lysosome pathway may contribute to the clearance of α-synuclein aggregates and protect against degeneration of dopaminergic neurons in Parkinson's disease. Moreover, multiple genes associated with the pathogenesis of Parkinson's disease are intimately linked to alterations in the autophagy-lysosome pathway. Thus, this pathway appears to be a promising therapeutic target for treatment of Parkinson's disease. In this review, we briefly introduce the machinery of autophagy. Then, we provide a description of the effects of Parkinson's disease-related genes on the autophagy-lysosome pathway. Finally, we highlight the potential chemical and genetic therapeutic strategies targeting the autophagy-lysosome pathway and their applications in Parkinson's disease.
Texto completo:
1
Base de datos:
MEDLINE
Idioma:
En
Revista:
Neural Regen Res
Año:
2025
Tipo del documento:
Article